Trospium chloride: IDEV completed enrollment of 524 patients in a double-blind, placebo-controlled U.S. Phase III trial of its trospium chloride to treat overac

Indevus Pharmaceuticals Inc. (INDV), Lexington, Mass.
Product: Trospium chloride
Business:

Read the full 105 word article

How to gain access

Continue reading with a
two-week free trial.